National Trends in Opioid Prescriptions Following Outpatient Otologic Surgery, 2005-2017.

Abstract

To describe opioid stewardship in ambulatory otologic surgery from 2005 to 2017. Descriptive study of US private insurance claims. Nationwide deidentified private insurance claims database (Clinformatics DataMart; Optum). A total of 17,431 adult opioid-naïve outpatients were included in the study. Patients were identified from <i>CPT-4</i> codes (<i>Current Procedural Terminology, Fourth Edition</i>) as having undergone middle ear or mastoid surgery. Multiple regression was used to determine sociodemographic and geographic predictors of postoperative morphine milligram equivalents (MMEs) prescribed, including procedure type, year of procedure, age, sex, education, income level, and geographic region of the United States. The mean prescribed perioperative dose over the examined period was 203.03 MMEs (95% CI, 200.27-205.79; 5-mg hydrocodone pill equivalents, 40.61). In multivariate analysis, patients undergoing mastoid surgery were prescribed more opioids than those undergoing middle ear surgery (mean difference, 39.89 MME [95% CI, 34.37-45.41], <i>P</i> < .01; 5-mg hydrocodone pill equivalents, 8.0). Men were prescribed higher doses than women (mean difference, 15.39 [95% CI, 9.87-20.90], <i>P</i> < .01; 5-mg hydrocodone pill equivalents, 3.1). Overall MMEs prescribed by year demonstrates a sharp drop in MMEs from 2015 to 2017. While the amount of opioids prescribed perioperatively has declined in recent years, otologists should continue to be cognizant of potential overprescribing in light of previous studies of patients' relatively low opioid intake.